With in-depth knowledge about human intestinal health and production of lactic acid fermented products, the idea arose to combine the two and launch human health products. Our CEO, Søren Kjærulff has a background as Biopharma R&D Director in Novozymes responsible for the discovery and development of antibacterial and anti-inflammatory drug candidates and, lately, also responsible for building a lactic acid bacteria platform.

Moreover, Søren has a PhD from Copenhagen University in molecular biology. Søren is supported by a sales and marketing team and a board of directors with broad knowledge of lactic acid fermentation from different branches as well as great top management skills.